Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately. (See "Society guideline links: Invasive fungal infections".)
International
●International Society for Heart and Lung Transplantation (ISHLT): Guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ transplant recipients – Executive summary, 2015 (published 2016)
Canada
●Canadian Paediatric Society (CPS): Practice point on antifungal agents for common outpatient paediatric infections (2019)
●Society of Obstetricians and Gynaecologists of Canada (SOGC): Clinical practice guideline on vulvovaginitis – Screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis (2015)
United States
●Centers for Disease Control and Prevention (CDC): Clinical overview of invasive candidiasis – For health care providers
●US Department of Health and Human Services (HHS): Federally approved clinical practice guidelines for HIV/AIDS
•Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV – Candidiasis (mucocutaneous) (2024)
•Guidelines for the prevention and treatment of opportunistic infections in children with and exposed to HIV – Candida infections (2020)
●American Academy of Pediatrics (AAP): Red Book – Candidiasis (2024)
●American Society for Transplantation and Cellular Therapy (ASTCT): Guideline for management of invasive candidiasis in hematopoietic cell transplantation recipients (2023)
●CDC: Sexually Transmitted Infections Treatment Guidelines – Vulvovaginal candidiasis (VVC) (2021)
●American Society of Transplantation (AST): Guidelines on Candida infections in solid organ transplantation (2019)
●Infectious Diseases Society of America (IDSA): Clinical practice guideline for the management of candidiasis, update (2016)
Europe
●European Society of Intensive Care Medicine (ESICM)/European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Task force on practical management of invasive candidiasis in critically ill patients (2019)
●European Conference on Infections in Leukaemia (ECIL): Guidelines for the treatment of invasive candidiasis, aspergillosis, and mucormycosis in leukemia and hematopoietic stem cell transplant patients (2017)
United Kingdom
●British HIV Association (BHIVA): Guidelines on the management of opportunistic infection in people living with HIV – The clinical management of candidiasis 2019, interim update (2022)
●British Association for Sexual Health and HIV (BASHH): National guideline for the management of vulvovaginal candidiasis, 2019 (published 2020)
Australia–New Zealand
●Australasian Sexual Health Alliance (ASHA): STI management guidelines for use in primary care – Candidiasis
●Australasian Antifungal Guidelines Steering Committee: Consensus guidelines for the diagnosis and management of invasive candidiasis in haematology, oncology, and intensive care settings (2021)
●Choosing Wisely Australia: Do not treat recurrent or persistent symptoms of vulvovaginal candidiasis with topical and oral anti-fungal agents without further clinical and microbiological assessment (2016)
Japan
●[In Japanese] Japanese Society of Medical Mycology (JSMM): Clinical practice guidelines for management of invasive candidiasis (2021)
